chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extremely fatigued; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 15:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 18:00, the patient experienced extremely fatigued and sore arm. The patient did not receive any treatment for the events. The clinical outcome of the events of extremely fatigued and sore arm was recovered on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After vaccine on Wednesday three fingers on my right hand went numb and my mouth felt like I had a shot of Novocain, then my tongue had a little tingling. I texted my doctor and he said to go to the ER and they checked me out did EKG, blood work, CAT scan, covid test that was negative and I was admitted.  I got an MRI and did other urine test, I was being checked every hour. I was given Plavix and other meds and was told that I had a stroke/TIA.
Site: Pain at Injection Site-Mild, Systemic: Chills-Medium, Systemic: Headache-Mild, Systemic: Elevated blood pressure. Rose to 140/110. No history of HTN. Returned to patient's normal blood pressure measure of 130/90 30-45 minutes after receiving the vaccine.
sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) outcome was unknown.            Concomitant medication was not provided Treatment information was not reported    Reporter did not allow further contact
tested positive on 02Jun2022; tested positive on 02Jun2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing); "known allergies: Aspirin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 02Jun2022, outcome "not recovered" and all described as "tested positive on 02Jun2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30May2022) Negative, notes: Tested negative with antigen test on 30May2022; (unspecified date) Unknown results; (02Jun2022) Positive, notes: Then some symptoms returned and tested positive on 02Jun2022. Therapeutic measures were taken as a result of drug ineffective, covid-19. Treatment for COVID-19 was initiated from 19May2022 to 24May2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Muscle sore; When caller period started there was a spotty brown; On and off nausea; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored Program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number and expiration date were not reported), via an unspecified route of administration on 06May2021 at 1ST DOSE, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced muscle sore, 'on and off nausea' and feels nauseous even if she eats or not and additionally when the patient was started with periods, there was a spotty brown observed in May2021 after the first dose of vaccination. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
PHN supervisor was notified by state that this patient was below the age requirement to receive this vaccine.  PHN contacted the patient's mother and notified her of this information. Patient's mother states that the child appears without any complaints or complications.
Pt received vaccine on 8/6/21.  Had a sore Right arm  until 1200 on 8/7/21.  At 0600 on 8/9/21 pt states woke up with rash on neck, left arm, trunk, back and legs.  Took 1 benadryl OTC at that time.  Received phone call from patient at approximately 8:20 am on 8/9/21 stating what had happened and that her rash was now improved but felt like skin was still itching/burning.  Told her to notify her PCP for further treatment options.  Check on patient at 11:20 am on 8/9 and she states that she still is itching has improved to bilat legs but continues to itch on left arm, neck, trunk and back area.  Call patient on 8/10/21 to check in with her.  She states that took an additional Benadryl around 1300 on 8/9/21 and that symptoms have since resolved except for a slight rash to neck area.  States that never went to doctor for follow up.  Pt instructed to follow up with PCP in regards to if she should receive second vaccine with pt verbalizing understanding.
redness, measuring 12cm in diameter at injection site. No tenderness. No lymphadenopathy.
On April 1, 2021,  started to develop  a painful, blistering rash spreading across right side of neck, front of upper-right side of chest, and upper right side of back and right upper shoulder. Topical ointments were futile.  was diagnosed with the Shingles by his family physician, , on April 5. Medications administered were: Valacyclovir HCL 1 gm tablet 7 day supply and Methylprednisolone 4 mg dose pack 6 day supply, and Calamine lotion daily. Symptoms abated finally on April 26.
Confirmed with the caller no other AE; a 13 year old patiant inadvertently received a dose of PROQUAD; This spontaneous report was received from a medical assistant referring to a 13-year-old patient of unknown gender. The patient's pertinent medical history, concomitant drugs and drug allergies were not reported.  On 14-APR-2021, the patient was inadvertently vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (albumin status recombinant Human albumin (rHA) (lot #: t0281391, expiration date: 15-FEB-2022, 1 dosage form, strength and route were not reported) for prophylaxis (inappropriate age at vaccine administration). It was confirmed that no other adverse event reported.
Patient was 17 at the time of injection. No reaction in 15 minutes following injection; no know treatment necessary.
A week after receiving the vaccine my father, the recipient, started developing an itchy rash. Nothing  over the counter was effective at curing or aided. The list of things taken were antihistamines, NSAIDs, and some creams. After another week of trying these methods he went to the doctor for a solutions in which he received a prescription. After a few days the rash started clearing up.
Headache for 2 days followed by numbness in finger on 3rd day, numbness in toes, foot and leg on 4th day, continued numbness in other fingers and toes thereafter.  Approximately 1 week after the vaccine, some feeling started to return to the initial numb sites.
Bad fatigue; migraine headache; muscle and joint pain; muscle and joint pain; body aches; upset stomach; fever; chills; This is a spontaneous report from a contactable pharmacist. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on 16Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration on 26Mar2021 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021, the patient experienced bad fatigue, migraine headache, muscle and joint pain, body aches, upset stomach, fever and chills. The clinical outcome of the events bad fatigue, migraine headache, muscle and joint pain, body aches, upset stomach, fever and chills was recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient received vaccination on 3/21/17 at PCP clinic visit. He called nurse on 5/3/17 about supplies and reported that he experienced numbness on the right side of his face for approx 3 weeks following administration of immunization.
Had shot at 330pm, went home and nose started terrific itching, and continued for 1 day. Called Pharmacist, and he thought reaction was from flu vaccine.That night felt drugged and almost called 911. Next am took Benadryl. Helped some. On 11\12 stopped Benadryl, itching subsided.
sick; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), on 27Apr2022 as dose 4 (booster), single (Lot number: FK9894) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "She only has one kidney, and later stated she was only born with one" (unspecified if ongoing), notes: She only has one kidney, and later stated she was only born with one; "allergic to Sulfa", start date: 1980 (unspecified if ongoing), notes: She is allergic to Sulfa - diagnosed in 1980's.; "bladder infection", start date: 1980 (unspecified if ongoing), notes: She later stated she had a bladder infection in the 1980's and was prescribed a medication that had sulfa in it that her doctor said she was allergic to, but she cannot remember the name and does not have a lot or expiration.; "Hysterectomy" (unspecified if ongoing), notes: She had a Hysterectomy when she was 18., They took the uteruses out.; "She found out she was born with 2 uteruses" (unspecified if ongoing), notes: She found out she was born with 2 uteruses. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot Number:  EN6202, Anatomical Location: left arm, Administration time: late morning.), administration date: 24Feb2021, when the patient was 65-year-old, for COVID-19 Immunization, reaction(s): "Joint aches", "headache", "chills", "dizziness", "fever", "leg cramps", "body aches", "tires out faster", "when going up and down stairs, breathing was harder"; BNT162b2 (DOSE 1, SINGLE, Lot Number:  EN6202, Anatomical Location: left arm, Administration time: late morning.), administration date: 24Feb2021, when the patient was 65-year-old, for Covid-19 Immunization, reaction(s): "sick"; BNT162b2 (DOSE 2, SINGLE, Lot Number: ER8727, Anatomical Location: left arm,), administration date: 17Mar2021, when the patient was 65-year-old, for Covid-19 Immunization, reaction(s): "sick"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE, Lot number: FF2587, Anatomical location: Injected in unsure if left or right arm), administration date: 20Oct2021, when the patient was 65-year-old, for Covid-19 Immunization, reaction(s): "when she saw him coming to her, it was like a fisheye peephole in an apartment", "Sick". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick".  Additional information: It was reported that, every time she got vaccine, she got 5th one on Monday (10Oct2022), she got sick.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201224579 similar report from same reporter;
Pt received the pediatric formulation of the COVID-19 vaccine, and should have received the 12 and older formulation.
Shingrix + administration of 2nd dose in less than recommended interval; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 21-year-old female patient who received Herpes zoster (Shingrix) (batch number 5954H, expiry date 15-AUG-2025) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 06-JUL-2023, the patient received the 2nd dose of Shingrix. On 06-JUL-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Shingrix + administration of 2nd dose in less than recommended interval). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 06-JUL-2023 The reporter reported that patient received second dose of Shingrix vaccine 2 days after received first dose. The vaccine administration facility was the same as primary reporter. The reporter did consent to follow up. The patient received 2nd dose of Shingrix early than recommended time frame, which led to shortening of vaccination schedule.
Patient has rash from injection site down to elbow and lymph node on that side is tender.
can't keep eyes open; ache all over; chills; they just lay down and sleep; then they are cold; they have a headache; still get this annoying thing that will pop up; This is a spontaneous report from contactable consumer. This consumer reported for a female patient (2nd cousin). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. On an unspecified date the patient experienced can't keep eyes open, ache all over, chills, they just lay down and sleep, then they are cold, they have a headache, still get this annoying thing that will pop up. Clinical course was reported as she was going to call a while back and she thought no, until she spoke with her cousin who had the same thing she went through. Report 2 of 2. Report 2 is she reporting on her cousins. She has a first cousin and her sister who live in and they had their shots pretty close the same time she did. Talking to her cousin, she has gone through the same thing and wanted her to find out if this is the same. There was a tough spell 4 days after the shot, then she was fine, then the same thing happened again for a couple of days at a time were they can't keep their eyes open because they ache all over, have chills, and then it goes away and then comes back. she adds her other cousin had the same shots and she did the same thing she had. She does not want to complete her report or complete a report on her cousins. That it has been the same for them as hers, their last shot was a few days before her second one. hey had the exact same thing happen. She does not know if maybe it is in the DNA or something. They still get this annoying thing that will pop up and they just lay down and sleep, then they are cold, then they have a headache. It does not last long, a day or a day and a half. The clinical outcome of events they just lay down and sleep, cold, headache was recovered and another still get this annoying thing that will pop up was not recovered other was unknown.  Information about lot/batch number has been requested.
This is a spontaneous report received from a noncontactable consumer (patient). A 54-year-old female (non-pregnant) patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine; solution for injection; batch/lot# EW0173 or EW0158; expiry date not reported), at the age of 54, via an unspecified route of administration, on unknown date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient did not have COVID-19 prior to vaccination and was not tested post vaccination. The patient experienced tinnitus, numbness and tingling in all extremities. She felt like electricity pulsing through her body. She got headaches and ringing in ears for months after shot. The patient had bloodwork, CT, MRI and nerve conduction test (all normal). The patient did not receive treatment in response to the events. All events lead to emergency room visit and physician office visit. The outcome of the events: not recovered (at the time of the report). No follow-up attempts possible. No further information expected.
EMPLOYEE NOTICED AN INCREASE IN HER HEART RATE APPROXIMATELY 5 MINUTES AFTER RECEIVING THE MODERNA COVID VACCINE. SHE NOTIFIED MONITORING NURSE WHO BEGAN COLLECTING VITAL SIGNS AND ESCALATED TO LEAD. LEAD, OBSERVED EMPLOYEES PULSE OF 125. EMPLOYEE REMAINED SEATED IN MONITORING ROOM FOR 35 MINUTES. PROVIDED HER WITH WATER TO DRINK. PULSE REASSESSED 35 MINUTES AFTER ADMINISTRATION AND REST AND PULSE WAS STILL ELVATED AT 118. EMPLOYEE INSTRUCTED TO CONTACT PCP OR URGENT CARE WITH ANY CONCERNS OR IF OTHER SYMPTOMS DEVELOP. EMPLOYEE DROVE SELF HOME AS SHE HAD NO OTHER CONCERNS.
4-9-21 vaccination Later that evening, I basically feeling 'outside of myself' like my 'spirit left my body'. Took me a week to feel like myself.  I had the headaches, felt sluggish, lethargic for a week. I was unable to do normal daily activities. I went to see my PCM on 4-12-21. He did some medical tests / labs. Results were negative for clots. They said I have a cyst on the back of my leg. Waiting on results of my MRI.  *HA are ongoing.
This spontaneous report was received from a healthcare worker and refers to a 6 month old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 22-JUN-2017 the patient was inadvertently administered a dose of VAQTA lot # N005274, expiration date 03-APR-2018, for prophylaxis (dose, route and site of administration were not reported). No adverse effects were reported.
Patient at clinic to receive Johnson & Johnson vaccine. Patient started complaining of being lightheaded. BP was 112/65, pulse 82, Temp 98.5, O2 sat 99. Patient began having tremors and weakness when standing. Physician evaluated patient. Patient became short of breath when talking. Physician ordered 50 mg Benadryl IM and advised staff to call ER. Patient taken to hospital emergency. A message was left for family to inform them. Member was discharged home same day.
Patient age 16 given PPSV23 when she was suppose to get HPV vaccine. No reactions to any vaccines. Other vaccines given at the time was MCV4.
Sweating, itchy/burning rash over entire body, stinging tongue, diarrhea. Acute onset, better with Benadryl.
Approx 10-15 minutes after the shot client started c/o severe nausea and did vomit. He was sweating, and c/o throat tightening, was pale and still nauseated. Benadryl 50 mg Im given. His brother in law was called to drive him home. After he was stable, and no longer c/o any symptoms he was release to his brother-in=law. He says he went home and slept 3 hours and then slept til noon the next day which is not  normal for him.
Headaches, denies resp symptoms multiple hives from right axilla arm to thigh. Scattered on left side.
7 X 5 cm welt on right arm with redness in middle. Patient states that it itches, only sensitive to touch.
This spontaneous report as received from a pharmacist refers to an unknown number of patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly stored LIQUID PEDVAXHIB (lot # K026533, expiration date: 07-AUG-2017 and lot# K026532, expiration date: 07-AUG-2017) dose and route were not reported. No adverse symptoms reported. This is one of two reports received from the same source. Additional information has been requested.
I received the FloBloc vaccine from my doctor's office and within 30 minutes, had red bright welts along my neck, shoulder, back and top of chest. It has not been 9 days and there are still marks on my skin. The doctor and a specialist, allergist, were not aware of any side effects and I have no history of allergies to to vaccinations.
Cold; Vaccination site pain/Arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) and VACCINATION SITE PAIN (Vaccination site pain/Arm hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination.    Co-suspect products included non-company products COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for Prophylactic vaccination and ADALIMUMAB for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form, first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (Intramuscular) 1 dosage form and ADALIMUMAB (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold) and VACCINATION SITE PAIN (Vaccination site pain/Arm hurt). At the time of the report, NASOPHARYNGITIS (Cold) and VACCINATION SITE PAIN (Vaccination site pain/Arm hurt) outcome was unknown.            No concomitant medication provided. No treatment medication provided.
PATIENT CONTACTED OUR OFFICE ON 4/14/2021 BASED ON THE RECOMMENDATION OF HER PRIMARY CARE PHYSICIAN.  SHE REPORTED, THAT SHORTLY AFTER THE FIRST MODERNA VACCINATION ON 4/2/21 SHE HAD A DROP IN BLOOD PRESSURE, AND HOURS LATER ON THE SAME DAY SHE NOTED A CENTRAL BLURRED VISION IN HER RIGHT EYE LASTING FOR 4-5 DAYS, THEN GETTING BETTER.  AFTER ADVISING HER ON 4/14/2021 OVER THE PHONE THAT SHE NEEDS TO BE SEEN, SHE CAME TO OUR CLINIC FOR EVALUATION.   OUR EXAMINATION ON 4/14/2021 REVEALED THE FOLLOWING.  SHE HAS FLUID UNDER HER RETINA OF HER RIGHT EYE.  THIS WAS DETERMINED VIA OCT (OPTICAL COHERENCE TOMOGRAPHY).  THE DIAGNOSIS WAS DETERMINED TO BE CENTRAL SEROUS RETINOPATHY (H35.711).
Bright red hives all over face and neck that have persisted for 2 days straight and continue to worsen. In addition to the following symptoms which occurred 7 hours after receiving the vaccine and lasted 36 hours.   1. Fever above 101 F 2. Chills, nausea, muscle soreness and weakness 3. Fatigue 4. Migraine
(R) arm swollen, very painful, dizzy, vomiting, sweating, chills. Better day 2, arm still remains tender to touch.
The patient developed erythema and tenderness of the left upper arm on 10/17.  On 10/18 the patient developed one maculopapular rash on the forehead.
Pt exp erythema, induration, inflammation, & swelling @ the inject site p/receiving vax;
Ear (right) was a little uncomfortable - it gradually got worse - by Tuesday afternoon, I went to my fitness class but tapped out half way through and it was around 6 pm that I went to urgent care.  Had an ear infection and was given a ten day regimen of amoxicillin. My ear is much better today.